Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
Abroad (travel likely)RecruitingPHASE3
Conditions
Bladder (Urothelial, Transitional Cell) Cancer · Non-Muscle Invasive Bladder Carcinoma · Non-muscle Invasive Bladder Cancer With Carcinoma in Situ
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
East Valley Urology Center of Arizona, Queen Creek, Arizona, United States
Contact: Study coordinator (Use Central Contact)Arkansas Urology, Little Rock, Arkansas, United States
Contact: Study coordinator (Use Central Contact)Michael Oefelein Clinical Trials, Bakersfield, California, United States
Renown Regional Medical Center, St Louis, Missouri, United States
Contact: Study coordinator (Use Central Contact)START - Carolinas, Myrtle Beach, South Carolina, United States
Contact: Study coordinator (Use Central Contact)Arensia Kapitanivka - PPDS, Kapitanivka, Ukraine
Contact: Study coordinator (Use Central Contact)